EPAM Systems, an NYSE-listed leading digital transformation services and product engineering company has announced the acquisition of Odysseus Data Services, Inc. for an undisclosed amount.
The acquisition aims to utilize Odysseus services to enhance EPAM’s capabilities in transforming the life sciences value chain through advanced data analytics, data methods, and artificial intelligence (AI).
Speaking on the acquisition, Killian, Senior Vice President of Life Sciences at EPAM said, “We are pleased to have Odysseus join EPAM. With their strong capabilities in Real-World Evidence and Real-World Data — the ‘glue’ between multiple segments of the life sciences value chain — our natural synergies make this an exciting time to add this to our portfolio to help our clients achieve better outcomes.”
“We see the next wave of innovation based on standardized data powering AI and GenAI to improve life sciences research, clinical studies, and post-market surveillance. Based on the combined strengths of EPAM and Odysseus, we are well positioned to lead that innovation,” Killian added.
Headquartered in Cambridge, Massachusetts, Odysseus generates healthcare data insights and evidence for clients through skilled data science and analytics, software engineering and data management, and ontology and vocabulary management.
The company’s focus on a standardized and systematic approach to healthcare data analytics is the foundation for a better understanding of the inner workings of healthcare interventions in drug treatment, drug safety and efficacy, epidemiological research, provider support, quality measurements, and cost reduction.
Commenting on the development, Gregory Klebanov, CEO of Odysseus said, “We’re excited to join the EPAM family. With EPAM’s strong foundation in AI, machine learning, data analytics, data management, and cloud infrastructure combined with our healthcare data analytics and Real World Evidence expertise, we can address the whole life sciences value chain more comprehensively.”
